(Reuters) -Two doses of Eli Lilly’s weight-loss drug Zepbound are expected to remain in short…
U.S. Steel union rejects Nippon Steel’s appeal for takeover support
(Reuters) -The union representing employees of United States Steel on Tuesday said it would not…
Fed officials see three rate cuts ‘reasonable’ this year
By Ann Saphir and Michael S. Derby (Reuters) -A pair of Federal Reserve policymakers often…
NATO boss floats 100 billion euro military aid fund for Ukraine
By Andrew Gray and John Irish BRUSSELS (Reuters) – NATO boss Jens Stoltenberg has proposed…
Biden administration weighing $18 billion in arms transfers to Israel, sources say
By Humeyra Pamuk, Patricia Zengerle and Matt Spetalnick WASHINGTON (Reuters) – President Joe Biden’s administration…
Trump Media shares plummet 21% days after debut
By Yuvraj Malik and Priyanka G (Reuters) -Shares of Donald Trump’s social media company plunged…
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
By Blake Brittain (Reuters) -Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday…
OpenAI makes ChatGPT’s accessible without requiring sign ups
(Reuters) – OpenAI will start allowing users to access its free-to-use ChatGPT generative AI chatbot…
Citi says 42% of energy clients lack climate transition plans
By Isla Binnie NEW YORK (Reuters) – Almost half of the energy companies Citi lends…
Home Depot bulks up Pro-business with $18.25 billion deal for building products supplier SRS
By Deborah Mary Sophia, Savyata Mishra and Abigail Summerville (Reuters) -Home Depot will buy building…